The global veterinary paraciticides market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for veterinary products and services in emerging economies such as China and India, which are witnessing an increase in pet ownership due to rising disposable incomes and changing lifestyles. In addition, the growing awareness about animal welfare among consumers has led to increased adoption of preventive measures against diseases such as heartworm disease, which can be prevented with regular use of veterinary paraciticides. Endoparasite segment accounted for the largest share in 2018 owing to its wide range of applications across various animals including dogs and cats. Ectoparasites segment is expected to grow at a higher CAGR during the forecast period owing to its wide range of applications across various animals including dogs and cats. North America accounted for the largest share in 2018 due to high demand from pet owners coupled with high awareness about animal welfare among consumers coupled with increasing disposable incomes leading them towards adopting preventive measures against diseases such as heartworm disease that can be prevented with regular use of veterinary paraciticides.
Some Of The Growth Factors Of This Market:
- The increasing number of pets in the world.
- The increasing awareness about animal health and welfare.
- The increase in the number of pet owners who are willing to spend more on their pets.
- Increasing demand for veterinary services.
Industry Growth Insights published a new data on “Veterinary Paraciticides Market”. The research report is titled “Veterinary Paraciticides Market research by Types (Endoparasite, Ectoparasites), By Applications (Dog, Cat, Other), By Players/Companies Pfizer, Merck, Sanofi-Aventis, Bayer HealthCare, Virbac, Novartis, Boehringer Ingelheim, Heska Corporation, Bioniche Animal Health Canada, Inc., Ceva, Johnson & Johnson, MedFly, Zoetis, 3M, R. M. Hatcheries, Lomir Biomedical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary Paraciticides Market Research Report
By Type
Endoparasite, Ectoparasites
By Application
Dog, Cat, Other
By Companies
Pfizer, Merck, Sanofi-Aventis, Bayer HealthCare, Virbac, Novartis, Boehringer Ingelheim, Heska Corporation, Bioniche Animal Health Canada, Inc., Ceva, Johnson & Johnson, MedFly, Zoetis, 3M, R. M. Hatcheries, Lomir Biomedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary Paraciticides Market Report Segments:
The global Veterinary Paraciticides market is segmented on the basis of:
Types
Endoparasite, Ectoparasites
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dog, Cat, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Merck
- Sanofi-Aventis
- Bayer HealthCare
- Virbac
- Novartis
- Boehringer Ingelheim
- Heska Corporation
- Bioniche Animal Health Canada, Inc.
- Ceva
- Johnson & Johnson
- MedFly
- Zoetis
- 3M
- R. M. Hatcheries
- Lomir Biomedical
Highlights of The Veterinary Paraciticides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Endoparasite
- Ectoparasites
- By Application:
- Dog
- Cat
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary Paraciticides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary paraciticides are a type of pesticide used to control parasites in animals. These pesticides kill parasites by disrupting their life cycles.
Some of the key players operating in the veterinary paraciticides market are Pfizer, Merck, Sanofi-Aventis, Bayer HealthCare, Virbac, Novartis, Boehringer Ingelheim, Heska Corporation, Bioniche Animal Health Canada, Inc., Ceva, Johnson & Johnson, MedFly, Zoetis, 3M, R. M. Hatcheries, Lomir Biomedical.
The veterinary paraciticides market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary Paraciticides Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Veterinary Paraciticides Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Veterinary Paraciticides Market - Supply Chain
4.5. Global Veterinary Paraciticides Market Forecast
4.5.1. Veterinary Paraciticides Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Veterinary Paraciticides Market Size (000 Units) and Y-o-Y Growth
4.5.3. Veterinary Paraciticides Market Absolute $ Opportunity
5. Global Veterinary Paraciticides Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Veterinary Paraciticides Market Size and Volume Forecast by Type
5.3.1. Endoparasite
5.3.2. Ectoparasites
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Veterinary Paraciticides Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Veterinary Paraciticides Market Size and Volume Forecast by Application
6.3.1. Dog
6.3.2. Cat
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Veterinary Paraciticides Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Veterinary Paraciticides Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Veterinary Paraciticides Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Veterinary Paraciticides Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Veterinary Paraciticides Demand Share Forecast, 2019-2026
9. North America Veterinary Paraciticides Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Veterinary Paraciticides Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Veterinary Paraciticides Market Size and Volume Forecast by Application
9.4.1. Dog
9.4.2. Cat
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Veterinary Paraciticides Market Size and Volume Forecast by Type
9.7.1. Endoparasite
9.7.2. Ectoparasites
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Veterinary Paraciticides Demand Share Forecast, 2019-2026
10. Latin America Veterinary Paraciticides Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Veterinary Paraciticides Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Veterinary Paraciticides Market Size and Volume Forecast by Application
10.4.1. Dog
10.4.2. Cat
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Veterinary Paraciticides Market Size and Volume Forecast by Type
10.7.1. Endoparasite
10.7.2. Ectoparasites
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Veterinary Paraciticides Demand Share Forecast, 2019-2026
11. Europe Veterinary Paraciticides Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Veterinary Paraciticides Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Veterinary Paraciticides Market Size and Volume Forecast by Application
11.4.1. Dog
11.4.2. Cat
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Veterinary Paraciticides Market Size and Volume Forecast by Type
11.7.1. Endoparasite
11.7.2. Ectoparasites
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Veterinary Paraciticides Demand Share, 2019-2026
12. Asia Pacific Veterinary Paraciticides Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Veterinary Paraciticides Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Veterinary Paraciticides Market Size and Volume Forecast by Application
12.4.1. Dog
12.4.2. Cat
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Veterinary Paraciticides Market Size and Volume Forecast by Type
12.7.1. Endoparasite
12.7.2. Ectoparasites
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Veterinary Paraciticides Demand Share, 2019-2026
13. Middle East & Africa Veterinary Paraciticides Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Veterinary Paraciticides Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Veterinary Paraciticides Market Size and Volume Forecast by Application
13.4.1. Dog
13.4.2. Cat
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Veterinary Paraciticides Market Size and Volume Forecast by Type
13.7.1. Endoparasite
13.7.2. Ectoparasites
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Veterinary Paraciticides Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Veterinary Paraciticides Market: Market Share Analysis
14.2. Veterinary Paraciticides Distributors and Customers
14.3. Veterinary Paraciticides Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi-Aventis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer HealthCare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Virbac
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Novartis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Boehringer Ingelheim
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Heska Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bioniche Animal Health Canada, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Ceva
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Johnson & Johnson
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. MedFly
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Zoetis
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. 3M
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. R. M. Hatcheries
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Lomir Biomedical
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook